NCT04817631 is a clinical trial of tuboovarian abscess in Tubo-ovarian Abscess, sponsored by Sisli Hamidiye Etfal Training and Research Hospital.

Who is sponsoring NCT04817631?

NCT04817631 is sponsored by Sisli Hamidiye Etfal Training and Research Hospital.

What drugs are being tested in NCT04817631?

Interventions in NCT04817631: tuboovarian abscess.

What condition does NCT04817631 study?

NCT04817631 studies Tubo-ovarian Abscess.

Is NCT04817631 still recruiting?

NCT04817631 is currently completed. Last updated 26 March 2021.

Last reviewed 2021-03-26 · How we verify

NCT04817631

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Management of Tubo-ovarian Abscess: a Single Center Experience

Completed Last updated 26 March 2021

What this trial tests

trial testing tuboovarian abscess in Tubo-ovarian Abscess in 82 participants. Completed in 1 November 2020.

Timeline

1 January 2010

Primary endpoint
1 November 2020

1 November 2020

Quick facts

Lead sponsor	Sisli Hamidiye Etfal Training and Research Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	82
Start date	1 January 2010
Primary completion	1 November 2020
Estimated completion	1 November 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

tuboovarian abscess

Conditions studied

Tubo-ovarian Abscess — all drugs for Tubo-ovarian Abscess →

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

18 and older, female only, with Tubo-ovarian Abscess. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Electronic database of our tertiary obstetrics and gynecology clinic was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

NCT07334002 — The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus · NA · not yet recruiting
NCT07321041 — Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia · recruiting
NCT07476690 — Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Pals · NA · recruiting
NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
NCT07250243 — Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04817631 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sisli Hamidiye Etfal Training and Research Hospital
Last refreshed: 26 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04817631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing